Clinical trial
Investigation of Macular Pigment Augmentation on Dark Adaptation
NCT00478439 · University of Alabama at Birmingham, Other · Terminated
Key facts
| NCT number | NCT00478439 |
|---|---|
| Title | Investigation of Macular Pigment Augmentation on Dark Adaptation |
| Official title | Investigation of Macular Pigment Augmentation on Dark Adaptation |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | ZeaVision, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Aging, Age-Related Macular Degeneration |
| Intervention type | Dietary Supplement |
| Interventions | ZeaVision EyePromise Restore, Multivitamin |
| Enrollment | 13 |
| Start date | Dec 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Oct 1, 2010 |
| First posted | May 24, 2007 |
| Last update posted | Oct 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: